Facial Block for Outpatient Rhinoplasty Analgesia

• Status: Unknown status
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A bilateral facial block (infraorbital and infratrochlear) will be performed immediately after intubation in patients undergoing outpatient rhinoplasty with 2.5% levobupivacaine (intervention group) or saline as control. Intravenous saline or morphine will be administered at the end of surgery in intervention or control groups, respectively. In case of pain in post-anesthesia care unit (numerical pain score >3 on a 0-10 scale), both groups will receive intravenous morphine titration. The total perioperative morphine consumption (intraoperative and in post-anesthesia care unit) will be compared between groups. Pain intensity, presence of nausea/vomiting and patient's satisfaction will be compared between groups.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospices Civils de Lyon
• Treatments: Anesthetics; Levobupivacaine

Criteria

Inclusion Criteria:

• Outpatient rhinoplasty

• American Society of Anesthesiologists (ASA) classification I-II

• Affiliated to Social Security

• Written informed consent

Exclusion Criteria:

• Allergy to levobupivacaine

• Incapacity to give consent

• Chronic pain